Voloridge Investment Management, LLC Tricida, Inc. Transaction History

Voloridge Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.95 - $5.41 $310,955 - $425,891	-78,723 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.52 - $7.8 $914,355 - $1.58 Million	-202,291 Reduced 71.99%	78,723 $416,000
Q4 2020 Feb 16, 2021	SELL	$4.37 - $9.46 $131,270 - $284,168	-30,039 Reduced 9.66%	281,014 $1.98 Million
Q3 2020 Nov 16, 2020	BUY	$8.56 - $26.93 $2.35 Million - $7.4 Million	274,753 Added 756.9%	311,053 $2.82 Million
Q2 2020 Aug 14, 2020	BUY	$21.21 - $31.55 $769,923 - $1.15 Million	36,300 New	36,300 $998,000
Q1 2020 May 15, 2020	SELL	$18.43 - $38.04 $277,574 - $572,920	-15,061 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$29.6 - $43.71 $445,805 - $658,316	15,061 New	15,061 $568,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.